|

Fingolimod Clinical Trials

4 actively recruiting trials across 2 locations

Also known as: FTY720

Pipeline

Phase 3: 1Phase 4: 2

Top Sponsors

  • Novartis Pharmaceuticals1
  • General Hospital of Shenyang Military Region1
  • Celgene1
  • Biogen1

Indications

  • Multiple Sclerosis3
  • Multiple Sclerosis, Relapsing-Remitting1
  • Diabetes1
  • Diabetes Mellitus, Type 21

Other2 trials

Fingolimod for Type 2 Diabetes Mellitus
Phase 4
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Phase 4

Loma Linda, California1 trial

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

Local Institution - 0114

Phase 3

Eden Prairie, Minnesota1 trial

A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies

OptumInsight

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.